.RESEARCH EMPHASIZE.06 August 2024.
A sizable randomized measured test along with cisgender women highlights the challenges of faithfulness to a regular oral preexposure prophylaxis program and also displays that twice-yearly shot of lenacapavir can easily maintain reliable HIV protection levels over 6 months.